AVTX Competitors & Alternatives
Compare Avalo Therapeutics Inc with similar stocks in the same industry
Biotechnology
AVTX
Main Stock$21.57
Tradestie Score
57
Market Cap
$170.45M
Revenue Growth
-0.7%
Analyst Upside
+85.9%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$44.23
|
$1.26B | - | 57 | Compare |
|
MPLT
MPLT
|
$27.40
|
$1.24B | - | 53 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 58 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$4.03
|
$1.22B | - | 53 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$4.21
|
$1.18B | - | 63 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$40.75
|
$1.17B | - | 55 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$22.89
|
$1.15B | 3.6 | 60 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$14.50
|
$1.14B | - | 62 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$8.85
|
$1.14B | - | 54 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$26.03
|
$1.13B | - | 55 | Compare |
More AVTX Analysis
Data updated: May 10, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry